TrialJournal of the American Society of Nephrology : JASN2025

Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial.

Andrew S Bomback et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.